REGENERON PHARMACEUTICALS, INC. Dividends Per Share
REGENERON PHARMACEUTICALS, INC. (REGN) reported Dividends Per Share of $0.94 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. common stock, dividends, per share, declared for the quarter ending 2026-06-30 was $0.94, a 6.82% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. common stock, dividends, per share, declared for the quarter ending 2026-03-31 was $0.94, a 6.82% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. common stock, dividends, per share, declared for the quarter ending 2025-12-31 was $0.88.
- REGENERON PHARMACEUTICALS, INC. common stock, dividends, per share, declared for the quarter ending 2025-09-30 was $0.88.
| Period end | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 6 month | Common Stock, Dividends, Per Share, Declared 9 month | Common Stock, Dividends, Per Share, Declared 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.94 10-Q · filed 2026-07-30 | $1.88 derived: sum of 2 quarters · filed 2026-07-30 | $2.76 derived: sum of 3 quarters · filed 2026-07-30 | $3.64 derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $0.94 10-Q · filed 2026-07-30 | $1.82 derived: sum of 2 quarters · filed 2026-07-30 | $2.70 derived: sum of 3 quarters · filed 2026-07-30 | $3.58 derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $0.88 10-K · filed 2026-02-04 | $1.76 derived: sum of 2 quarters · filed 2026-02-04 | $2.64 derived: sum of 3 quarters · filed 2026-02-04 | $3.52 derived: sum of 4 quarters · filed 2026-02-04 |
| 2025-09-30 | $0.88 10-K · filed 2026-02-04 | $1.76 derived: sum of 2 quarters · filed 2026-02-04 | $2.64 derived: sum of 3 quarters · filed 2026-02-04 | |
| 2025-06-30 | $0.88 10-K · filed 2026-02-04 | $1.76 derived: sum of 2 quarters · filed 2026-02-04 | ||
| 2025-03-31 | $0.88 10-K · filed 2026-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |